Insights On Outsourced Drug Development

31. N-Linked Glycan Analysis Of NISTmAb 8/11/2023

    With the right glycan analysis kit, you can achieve a 1-minute-per-sample analysis rate, along with streamlined and high-throughput glycan analysis assay for all phases of biopharmaceutical development.

32. How To Avoid Sticking And Picking In The Tableting Industry 9/23/2024

    Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.

33. Spray Drying To Enable New Inhaled Drug Products 7/11/2023

    The formulation and spray drying process can help manufacture a stable, highly respirable powder and deliver products that require a high drug load, a biologic, or rapid onset therapeutic.

34. Safety, Containment, And Analysis Of Highly Potent Compounds 5/16/2024

    Explore a comprehensive overview of the challenges, requirements, and best practices for safely working with highly potent compounds in drug development and manufacturing.

35. Maximizing CAR-T Cell Yields With Perfusion And Stirred-Tank Bioreactors 11/21/2024

    Join UCL experts in exploring how advanced perfusion techniques and stirred-tank bioreactors can enhance CAR-T cell manufacturing with improved yields, scale-up, and reduced costs.

36. Released N-Linked Glycan Analysis 8/9/2023

    Review a streamlined N-linked glycan analysis that employs an automated sample preparation with the magnetic bead-mediated glycan workflow followed by capillary electrophoresis.

37. Ophthalmic Drug Delivery 4/11/2024

    Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

38. A Smarter Strategy For Optimizing Oncology Drug Products 7/14/2023

    John McDermott, VP of Scientific Consulting, shares insights on the benefits of evaluating targeted oncology molecules in healthy volunteers and applying an effective platform to accelerate drug product optimization.

39. A New Framework For Identifying Nitrosamine Risks And Derisking Products 6/18/2024

    Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

40. Achieving Optimal CAR-T Cell Generation 10/9/2024

    Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.